NIDDK Information Network Coordinating Unit: dkNET-CU (U24 Clinical Trial Not Allowed) (RFA-DK-22-017)

National Institute of Diabetes and Digestive and Kidney Diseases

The renewal of the NIDDK Information Network (dkNET) provides increased budget, calls for diabetes researchers to join the program leadership, and anticipates close partnership with NIDDK research consortia. This Funding Opportunity Announcement (FOA) is to continue development and expansion of the NIDDK Information Network (dkNET) under the direction of the dkNET Coordinating Unit (dkNET-CU). dkNET supports the NIDDK community’s needs in data science by providing an information portal that connects users to data, analytical tools, and other biomedical research resources. Additionally, dkNET supports researchers by providing a hub for data-driven hypothesis generation; a suite of tools that assist users in FAIR (Findable, Accessible, Interoperable, Reusable) practice, and in improving rigor and reproducibility in research; and a variety of programs to enhance community engagement and workforce development. The dkNET-CU will be responsible for providing the scientific direction, vision, and administrative management to advance dkNET goals.

Posted: November 23, 2022
Full grant due: March 31, 2023
Start date: December 2023

Human Islet Research Network (HIRN) Pancreas Knowledgebase Program (PanKbase) (RFA-DK-22-018)

This Funding Opportunity Announcement (FOA) invites applications to develop a centralized resource of the human pancreas for diabetes research that will provide access to deeply curated high-quality datasets, knowledge in computable forms, and advanced data science tools and workflows; and enable open and reproducible multidisciplinary collaboration toward accelerating biomarker and therapeutic target development. The program will become a component of the Human Islet Research Network or HIRN (

Posted: October 4, 2022
Letter of Intent Due: February 28, 2023
Application Due Date: March 31, 2023
Start Date: December 2023

Integrated Physiology of Exocrine and Endocrine Pancreas in Type 1 Diabetes (R01 – Clinical Trial Not Allowed) (RFA-DK-22-022 )

National Institute of Diabetes and Digestive and Kidney Diseases

This Funding Opportunity will support multi-disciplinary teams to examine interactions between exocrine and endocrine pancreas to support the study of T1D. The purpose of this opportunity is to encourage integrated study of the whole pancreas to enable characterization of direct and indirect crosstalk between exocrine and endocrine compartments, and identification of the mechanisms by which that crosstalk occurs and can be disrupted in T1D and other forms of diabetes. Development of assays or platforms to allow for broader investigation into these questions could also be supported.Application due date:

Posted: July 29, 2022
Full grant due: February 22, 2023
Start date: December 2023

NIH Gateway Award for Collaborative T1D Research (RFA-DK-21-030)

The New Investigator Gateway Award in T1D Research is designed to support a robust pipeline of innovative projects and talented new investigators in T1D research. In addition to providing support for preliminary research, the Gateway program provides an opportunity for new Program Directors/Principal Investigators (PD/PIs) to pursue their studies within the intellectual environment of a select number of large, ongoing collaborative research programs. Embedding awardees within an established scientific framework in each of these consortia will provide unique opportunities for New and Early Stage Investigators to increase their understanding of key questions in the field, to network, and to establish unique and potentially long-lasting collaborations that will propel their careers forward. Bringing New and Early Stage Investigators into existing collaborative research networks will also benefit the networks by providing new ideas and perspectives. Learn more HERE.

Posted: December 3, 2021
Letter of Intent Due: May 1, 2022 and February 20, 2023
Application Due Date: June 1, 2022 and March 20, 2023
Start Date: May 2023 and December 2023

Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) (PAR-20-140)

National Institute of Diabetes and Digestive and Kidney Diseases

This Funding Opportunity Announcement (FOA) is intended to support tool or technology development projects, opening new areas of science or translational research. The projects supported by this FOA could involve proof-of-concept studies, prototyping, optimization of a technology for the unique anatomy or physiology of these organ systems, and refinement of technical specifications for subsequent deployment of the technology in laboratory or clinical settings.

Application due date: Standard dates apply
Expiration date: May 8, 2023



us on our social networks.